SICKLE CELL DISEASE COALITION Trademark

Trademark Overview

On Thursday, August 11, 2016, a trademark application was filed for SICKLE CELL DISEASE COALITION with the United States Patent and Trademark Office. The USPTO has given the SICKLE CELL DISEASE COALITION trademark a serial number of 87135588. The federal status of this trademark filing is REGISTERED as of Tuesday, November 17, 2020. This trademark is owned by American Society of Hematology, Inc.. The SICKLE CELL DISEASE COALITION trademark is filed in the Advertising, Business and Retail Services category with the following description:

Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of research relating to sickle cell disease; promoting the exchange of information and resources within medical communities to achieve advances in the field of training and clinical care related to sickle cell disease; public advocacy to promote awareness of sickle cell disease
sickle cell disease coalition

General Information

Serial Number87135588
Word MarkSICKLE CELL DISEASE COALITION
Filing DateThursday, August 11, 2016
Status700 - REGISTERED
Status DateTuesday, November 17, 2020
Registration Number6200631
Registration DateTuesday, November 17, 2020
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 21, 2017

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"SICKLE CELL DISEASE COALITION"
Description of MarkThe mark consists of a crescent design to the right of the words "SICKLE CELL" above the word "DISEASE" above the word "COALITION".
Goods and ServicesPromoting collaboration within the scientific, research and medical communities to achieve advances in the field of research relating to sickle cell disease; promoting the exchange of information and resources within medical communities to achieve advances in the field of training and clinical care related to sickle cell disease; public advocacy to promote awareness of sickle cell disease

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, August 17, 2016
Primary Code035
First Use Anywhere DateWednesday, August 31, 2016
First Use In Commerce DateWednesday, August 31, 2016

Trademark Owner History

Party NameAmerican Society of Hematology, Inc.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressWashington, DC 20036
Party NameAmerican Society of Hematology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressWashington, DC 20036
Party NameAmerican Society of Hematology, Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressWashington, DC 200364929

Trademark Events

Event DateEvent Description
Tuesday, November 17, 2020REGISTERED-PRINCIPAL REGISTER
Friday, October 16, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, October 15, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, October 15, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 15, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 15, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 24, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 24, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 24, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, April 19, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, April 19, 2020NON-FINAL ACTION E-MAILED
Sunday, April 19, 2020SU - NON-FINAL ACTION - WRITTEN
Friday, April 17, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 15, 2020USE AMENDMENT FILED
Wednesday, April 15, 2020TEAS STATEMENT OF USE RECEIVED
Friday, November 15, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 14, 2019EXTENSION 5 GRANTED
Tuesday, November 12, 2019EXTENSION 5 FILED
Tuesday, November 12, 2019TEAS EXTENSION RECEIVED
Tuesday, May 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 20, 2019EXTENSION 4 GRANTED
Wednesday, May 15, 2019EXTENSION 4 FILED
Wednesday, May 15, 2019TEAS EXTENSION RECEIVED
Saturday, November 17, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 16, 2018EXTENSION 3 GRANTED
Thursday, November 15, 2018EXTENSION 3 FILED
Thursday, November 15, 2018TEAS EXTENSION RECEIVED
Friday, May 25, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 24, 2018EXTENSION 2 GRANTED
Tuesday, May 15, 2018EXTENSION 2 FILED
Thursday, May 24, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 15, 2018TEAS EXTENSION RECEIVED
Wednesday, November 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 6, 2017EXTENSION 1 GRANTED
Monday, November 6, 2017EXTENSION 1 FILED
Monday, November 6, 2017TEAS EXTENSION RECEIVED
Monday, November 6, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 19, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 16, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 21, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 21, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 1, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 6, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 6, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 6, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 6, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 22, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 22, 2016NON-FINAL ACTION E-MAILED
Tuesday, November 22, 2016NON-FINAL ACTION WRITTEN
Tuesday, November 22, 2016ASSIGNED TO EXAMINER
Thursday, August 18, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, August 17, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, August 15, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

coalition disease cell sickle field within promoting achieve advances medical communities